Management of platinum-sensitive recurrent ovarian cancer (PSROC) in the era of biologics: Can ASCO's net health benefits (NHB) inform our decisions? Meeting Abstract
| Authors: | Foote, J.; Havrilesky, L. J.; Jewell, E. L.; Gamble, C.; Ehrisman, J.; Broadwater, G.; Coleman, R. L.; Cohn, D. E.; Secord, A. A. |
| Abstract Title: | Management of platinum-sensitive recurrent ovarian cancer (PSROC) in the era of biologics: Can ASCO's net health benefits (NHB) inform our decisions? |
| Meeting Title: | 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 35 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2017 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-05-20 |
| Start Page: | 297s |
| Language: | English |
| ACCESSION: | WOS:000411931704022 |
| DOI: | 10.1200/JCO.2017.35.15_suppl.5544 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 5544 -- Source: Wos |
